SynthesisBMC pregnancy and childbirth2026
The impact of CD138 plasma cell severity on IVF-ET outcomes in women with untreated chronic endometritis: a systematic review and meta-analysis.
Synthesis in BMC pregnancy and childbirth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectiveTo evaluate the impact of untreated chronic endometritis (CE) on in vitro fertilization (IVF) outcomes, with a specific focus on the differential effects of embryo transfer protocols and CE severity (stratified by CD138-positive plasma cell count).
methodsWe systematically searched PubMed, Web of Science, Scopus, the Cochrane Library, CNKI, Sinomed, VIP, and WanFang databases from their respective inception dates to 30 September 2025 for studies comparing IVF outcomes between women with untreated CE and those without CE. The quality of included studies was assessed using the Newcastle-Ottawa Scale. Disease severity was stratified as mild (1–4 CD138 + plasma cells per high-power field [HPF]) or severe (≥ 5 cells/HPF). The primary outcome was clinical pregnancy rate, while secondary outcomes were the live birth rate, early miscarriage rate, and embryo implantation rate.
resultsA total number of 3190 patients from ten studies were included. The overall analysis revealed that untreated CE was associated with a significantly reduced clinical pregnancy rate (nine studies, OR = 0.52, 95% CI: 0.32–0.84, p value = 0.008) compared to those without CE. Subgroup analysis within the frozen embryo transfer (FET) population revealed that mild CE (1–4 CD138 + plasma cells/HPF) showed no significant association with clinical pregnancy rate (four studies, OR = 0.94, p value = 0.78), severe CE (≥ 5 CD138 + plasma cells/HPF) was associated with reduced clinical pregnancy rate (three studies, OR = 0.26, p value = 0.02). Furthermore, the association of severe CE appeared to be stage-specific, being significantly associated with lower clinical pregnancy but not with embryo implantation rates, live birth rates, or early miscarriage rates in the FET population.
conclusionThis meta-analysis indicates that the severity of untreated chronic endometritis (CE) is associated with IVF outcomes in FET cycles. Women with severe CE (≥ 5 CD138 + cells/HPF) had lower clinical pregnancy rates, while those with mild CE (1–4 CD138 + cells/HPF) showed no significant association. This dose-response relationship underscores the importance of CD138 + based severity stratification and contributes to explaining a key source of heterogeneity in the existing literature. These findings warrant validation in prospective studies to define management thresholds.
trial registrationCRD420251266243.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.